Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The stratum corneum extracellular matrix and desquamation-related enzymes comprise a group of proteases and hydrolases essential for the terminal differentiation of the epidermis and the shedding of corneocytes (Egelrud, 2000). The primary enzymes involved are kallikrein-related peptidases, specifically KLK5 (stratum corneum tryptic enzyme), KLK7 (stratum corneum chymotryptic enzyme), and KLK14, along with cathepsins V, L, and D (Brattsand et al., 2005). These enzymes work in concert to degrade corneodesmosomes, the proteinaceous bridges containing desmoglein-1 and desmocollin-1 that maintain the integrity of the skin's outermost layer (Caubet et al., 2004). Proper regulation of this enzymatic activity is crucial for maintaining the skin barrier; for example, deficiency in the inhibitor LEKTI leads to the severe skin-shedding disorder Netherton syndrome due to KLK hyperactivation (Descargues et al., 2005). Conversely, reduced enzyme activity is a hallmark of xerosis and ichthyosis, where the skin becomes thickened and scaly. Pharmacological targeting of these enzymes often involves the use of keratolytics like salicylic acid or alpha-hydroxy acids, which modulate the local pH to optimize protease activity and facilitate desquamation (StatPearls, 2023).
Keratolytic activity through pH modulation and direct disruption of corneodesmosomal bonds to facilitate desquamation.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Stratum corneum extracellular matrix and desquamation-related enzymes.